A new chromogranin A–dependent angiogenic switch activated by thrombin

Angiogenesis, the formation of blood vessels from pre-existing vasculature, is regulated by a complex interplay of anti and proangiogenic factors. We found that physiologic levels of circulating chromogranin A (CgA), a protein secreted by the neuroendocrine system, can inhibit angiogenesis in variou...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 121; no. 2; pp. 392 - 402
Main Authors Crippa, Luca, Bianco, Mimma, Colombo, Barbara, Gasparri, Anna M., Ferrero, Elisabetta, Loh, Y. Peng, Curnis, Flavio, Corti, Angelo
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 10.01.2013
American Society of Hematology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Angiogenesis, the formation of blood vessels from pre-existing vasculature, is regulated by a complex interplay of anti and proangiogenic factors. We found that physiologic levels of circulating chromogranin A (CgA), a protein secreted by the neuroendocrine system, can inhibit angiogenesis in various in vitro and in vivo experimental models. Structure-activity studies showed that a functional anti-angiogenic site is located in the C-terminal region, whereas a latent anti-angiogenic site, activated by cleavage of Q76-K77 bond, is present in the N-terminal domain. Cleavage of CgA by thrombin abrogated its anti-angiogenic activity and generated fragments (lacking the C-terminal region) endowed of potent proangiogenic activity. Hematologic studies showed that biologically relevant levels of forms of full-length CgA and CgA1-76 (anti-angiogenic) and lower levels of fragments lacking the C-terminal region (proangiogenic) are present in circulation in healthy subjects. Blood coagulation caused, in a thrombin-dependent manner, almost complete conversion of CgA into fragments lacking the C-terminal region. These results suggest that the CgA-related circulating polypeptides form a balance of anti and proangiogenic factors tightlyregulated byproteolysis. Thrombin-induced alteration of this balance could provide a novel mechanism for triggering angiogenesis in pathophysiologic conditions characterized by prothrombin activation. •Circulating chromogranin A and its fragments form a balance of anti- and pro-angiogenic factors regulated by thrombin-dependent cleavage.•The alteration of this balance could provide a new mechanism for triggering angiogenesis in cancer and other pathophysiologic conditions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-4971
1528-0020
1528-0020
DOI:10.1182/blood-2012-05-430314